{"title":"Neural interface instructs layer 4-appropriate circuit reconstruction with engrafted human brain organoids and improves visually guided behavior.","authors":"Zhe-Han Chang, Jian-Xin Shi, Chong Chen, Xiong-Gang Yang, Peng-Fei Hu, Jia-Chen Chen, Zhan-He Zhang, Nan Hu, Jing Hu, Qiang Yang, Wen-Wei Shao, Yun-Liang Zang, Sheng Lu, Xiao-Hong Li","doi":"10.1016/j.stem.2026.10.011","DOIUrl":"https://doi.org/10.1016/j.stem.2026.10.011","url":null,"abstract":"<p><p>Repairing precise neural microcircuitry after cortical injury remains a pivotal challenge. Human brain organoids (hBOs) are a promising cell source, but disorganized integration limits their therapeutic potential. Here, we demonstrated that targeted neuromodulation, steered by endogenous narrowband gamma (NBG) rhythms, instructed structural and functional integration of hBO grafts in the injured adult mouse visual cortex. Using a neural interface system, we promoted general graft-host coupling and then delivered NBG-rhythmic stimulation to specific functional clusters. This strategy guided the emergence of layer 4-appropriate molecular and functional properties in grafts, enabled bidirectional connectivity with the host visual circuit, and supported the development of advanced visual processing, including direction selectivity in hBO neurons. Electrophysiologically, graft spiking phase locked to host NBG oscillations. Behaviorally, host visual acuity and contrast sensitivity were significantly restored. Our work established a framework for circuit-level repair, highlighting a synergistic strategy that moves beyond cell replacement to direct the assembly of neural grafts.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":" ","pages":""},"PeriodicalIF":20.4,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149358458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.10.005
Daniel M Tremmel, Yonglin Zhu, Juan M Melero-Martin
{"title":"Integrating blood vessel organoids makes stem cell-derived islets more competent.","authors":"Daniel M Tremmel, Yonglin Zhu, Juan M Melero-Martin","doi":"10.1016/j.stem.2026.10.005","DOIUrl":"https://doi.org/10.1016/j.stem.2026.10.005","url":null,"abstract":"<p><p>Wang et al. present an all-stem-cell strategy that vascularizes pancreatic islet organoids by integrating them with blood vessel organoids, enhancing β cell maturation and resilience and reversing diabetes in mice.<sup>1</sup> The resulting model offers a platform to study islet-vascular biology in vitro and to advance transplantation therapies.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1736-1737"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345100","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.10.002
Zhenglin Dong, Yan Wu, Jiacan Su
{"title":"Enabling autonomous remodeling in bone organoids.","authors":"Zhenglin Dong, Yan Wu, Jiacan Su","doi":"10.1016/j.stem.2026.10.002","DOIUrl":"https://doi.org/10.1016/j.stem.2026.10.002","url":null,"abstract":"<p><p>Recreating bone remodeling remains challenging in bone organoids. In this issue of Cell Stem Cell, Pinho et al.<sup>1</sup> develop bone organoids within liquefied microcapsules that support osteoblast, osteocyte, and osteoclast differentiation without exogenous differentiation inducers. This model supports matrix deposition and resorption, enabling investigation of cellular interactions underlying bone remodeling.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1740-1742"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05Epub Date: 2026-10-28DOI: 10.1016/j.stem.2026.09.016
Dawn S Lin, Isabell Alexandra Guckes, Ian Ghezzi, Pia Sommerkamp, Esther Rodríguez-Correa, Enrico Frigoli, Santiago Cerrizuela, Lukas P M Kremer, Sina Bergemann, Nesrine Aroua, Frank Y Huang, Patrick Stelmach, Andreas Narr, Mari Carmen Romero-Mulero, Petra Zeisberger, Markus Sohn, Simon Anders, Marieke A G Essers, Nina Cabezas-Wallscheid, Ana Martin-Villalba, Michael D Milsom, Maria C Puschhof, Andreas Trumpp
{"title":"EPCR expression marks CD150<sup>neg</sup> deeply dormant long-term hematopoietic stem cells.","authors":"Dawn S Lin, Isabell Alexandra Guckes, Ian Ghezzi, Pia Sommerkamp, Esther Rodríguez-Correa, Enrico Frigoli, Santiago Cerrizuela, Lukas P M Kremer, Sina Bergemann, Nesrine Aroua, Frank Y Huang, Patrick Stelmach, Andreas Narr, Mari Carmen Romero-Mulero, Petra Zeisberger, Markus Sohn, Simon Anders, Marieke A G Essers, Nina Cabezas-Wallscheid, Ana Martin-Villalba, Michael D Milsom, Maria C Puschhof, Andreas Trumpp","doi":"10.1016/j.stem.2026.09.016","DOIUrl":"10.1016/j.stem.2026.09.016","url":null,"abstract":"<p><p>Cell surface expression of the Slam family member CD150 is widely used for the prospective isolation of multipotent long-term hematopoietic stem cells (LT-HSCs). Here, we identify a bona fide endothelial protein C receptor (EPCR)<sup>+</sup>CD150<sup>-</sup> HSC subset, termed LT-HSC2, that sustains serial multi-lineage reconstitution. Long-term label-retaining assays reveal that LT-HSC2s are more deeply dormant than conventional EPCR<sup>+</sup>CD150<sup>+</sup> LT-HSC1s, exhibit reduced cell cycle activation in response to inflammatory stress, and preserve stemness for prolonged periods in vivo. Moreover, combining EPCR with established HSC and multipotent progenitor (MPP) markers resolves the earliest stages of lineage divergence toward megakaryocytic/erythroid-biased CD150<sup>+</sup> and lymphoid-biased CD150<sup>-</sup> trajectories. Thus, EPCR expression in HSCs and MPPs is associated with increased stemness, whereas CD150 expression does not encompass the full spectrum of long-term repopulating HSCs. Our findings establish EPCR<sup>+</sup>CD150<sup>-</sup> LT-HSC2s as a distinct, exceptionally dormant stem-cell subset and reveal an additional layer of HSC heterogeneity governing self-renewal, decreased stress sensitvity. and earliest lineage priming.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":" ","pages":"1840-1856.e7"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149290626","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Organoids and organs-on-a-chip as new approach methodologies at the convergence of cell biology and bioengineering.","authors":"Daniel Naveed Tavakol, Danielle Mendonca, Ilaria Baldassarri, Mirjana Maletic-Savatic, Gordana Vunjak-Novakovic","doi":"10.1016/j.stem.2026.10.003","DOIUrl":"10.1016/j.stem.2026.10.003","url":null,"abstract":"<p><p>The rapid growth of new approach methodologies (NAMs), including organoids and organs-on-a-chip (OOCs), has revealed a need for interdisciplinary dialogue between cell biologists and bioengineers to develop human models that can best complement therapeutic development. Stem cell-derived and bioengineered human tissue models are redefining how we understand human physiology and pathophysiology, offering control that traditional preclinical models cannot provide. By recapitulating complex tissue microenvironments, multi-organ interactions, and patient-specific biology, these systems are bridging long-standing gaps in the drug development and clinical application pipelines. Here, we synthesize advances in organoids, OOCs, and other bioengineered technologies for translational medicine to identify remaining gaps, including challenges in reproducibility, validation, and regulatory acceptance. Emerging opportunities at the intersection of synthetic biology, multi-omics, machine learning, and genetic engineering are positioning NAMs not merely as improved experimental tools but as foundational platforms for accelerating therapeutic discovery and enabling personalized medicine at scale.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":" ","pages":"1753-1767"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13726884/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149290611","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.09.007
Maria Kasper, Maksim V Plikus
{"title":"Wound fibroblasts arrive in the right place at the right time.","authors":"Maria Kasper, Maksim V Plikus","doi":"10.1016/j.stem.2026.09.007","DOIUrl":"https://doi.org/10.1016/j.stem.2026.09.007","url":null,"abstract":"<p><p>What principles guide fibroblasts to maintain or repair tissues has long remained unresolved due to substantial molecular overlap among cell populations. Writing in Cell Stem Cell, Guo et al. used a two-gene labeling strategy to lineage-trace fibroblasts at high resolution as they heal skin wounds from bottom to top.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1733-1735"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.09.017
Ruohan Feng, Xue Pang, Yi Hao, Tong Zhao, Yaojin Peng
{"title":"China rewrites its regulatory framework for stem cell clinical translation.","authors":"Ruohan Feng, Xue Pang, Yi Hao, Tong Zhao, Yaojin Peng","doi":"10.1016/j.stem.2026.09.017","DOIUrl":"https://doi.org/10.1016/j.stem.2026.09.017","url":null,"abstract":"<p><p>China's 2026 reform creates a new dynamic regulatory architecture for stem cell and other advanced biomedical technology research and translation that moves these areas beyond the drug-versus-technology divide. Through revocable clinical-use authorization, life cycle surveillance, and mandatory exit, it seeks to align clinical access with safety oversight and evidentiary validation.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1748-1752"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.10.013
Jeongmin Seo, Sojung Kim, Jina Lee, Yongjin Yoo
{"title":"Not born in the brain: Bone marrow-derived microglia in human aging.","authors":"Jeongmin Seo, Sojung Kim, Jina Lee, Yongjin Yoo","doi":"10.1016/j.stem.2026.10.013","DOIUrl":"https://doi.org/10.1016/j.stem.2026.10.013","url":null,"abstract":"<p><p>In a study recently published in Nature, Belk et al.<sup>1</sup> use somatic mutations to demonstrate that bone marrow-derived cells enter the aging human brain and resemble microglia. The aged microglial compartment may therefore have a substantial hematopoietic contribution, and its clonal composition may prove important for stem-cell-based microglial replacement.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1745-1747"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Cell stem cellPub Date : 2026-11-05DOI: 10.1016/j.stem.2026.10.001
Ian S Kinstlinger, Wilson W Wong
{"title":"Subtractive genetic circuits improve organoid development.","authors":"Ian S Kinstlinger, Wilson W Wong","doi":"10.1016/j.stem.2026.10.001","DOIUrl":"https://doi.org/10.1016/j.stem.2026.10.001","url":null,"abstract":"<p><p>What if you want to remove unwanted cells in developing organoids? In this issue of Cell Stem Cell, Taheri, Xiang, et al.<sup>1</sup> engineered synthetic gene circuits in an iPSC line and used them to delete less mature cells in developing liver organoids and embryoids, leading to more mature phenotypes.</p>","PeriodicalId":93928,"journal":{"name":"Cell stem cell","volume":"33 11","pages":"1738-1739"},"PeriodicalIF":20.4,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149345103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}